127 related articles for article (PubMed ID: 36504922)
1. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months.
Pinto Pereira SM; Shafran R; Nugawela MD; Panagi L; Hargreaves D; Ladhani SN; Bennett SD; Chalder T; Dalrymple E; Ford T; Heyman I; McOwat K; Rojas NK; Sharma K; Simmons R; White SR; Stephenson T
Lancet Reg Health Eur; 2023 Feb; 25():100554. PubMed ID: 36504922
[TBL] [Abstract][Full Text] [Related]
2. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study.
Stephenson T; Pinto Pereira SM; Nugawela MD; McOwat K; Simmons R; Chalder T; Ford T; Heyman I; Swann OV; Fox-Smith L; Rojas NK; Dalrymple E; Ladhani SN; Shafran R;
PLoS One; 2023; 18(3):e0277704. PubMed ID: 36877677
[TBL] [Abstract][Full Text] [Related]
3. Post-COVID-19 condition at 6 months and COVID-19 vaccination in non-hospitalised children and young people.
Pinto Pereira SM; Nugawela MD; Rojas NK; Shafran R; McOwat K; Simmons R; Ford T; Heyman I; Ladhani SN; Cheung EY; Fox-Smith L; Dalrymple E; Stephenson T
Arch Dis Child; 2023 Apr; 108(4):289-295. PubMed ID: 36599625
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant).
Foret-Bruno P; Shafran R; Stephenson T; Nugawela MD; Chan D; Ladhani S; McOwat K; Mensah A; Simmons R; Fox Smith L; D'oelsnitz A; Xu L; Dalrymple E; Heyman I; Ford T; Segal T; Chalder T; Rojas N; Pinto Pereira SM;
Brain Behav Immun; 2024 Jul; 119():989-994. PubMed ID: 38735404
[TBL] [Abstract][Full Text] [Related]
5. Symptom Profiles of Children and Young People 12 Months after SARS-CoV-2 Testing: A National Matched Cohort Study (The CLoCk Study).
Pinto Pereira SM; Nugawela MD; McOwat K; Dalrymple E; Xu L; Ladhani SN; Simmons R; Chalder T; Swann O; Ford T; Heyman I; Segal T; Semple MG; Rojas NK; CLoCk Consortium ; Shafran R; Stephenson T
Children (Basel); 2023 Jul; 10(7):. PubMed ID: 37508724
[TBL] [Abstract][Full Text] [Related]
6. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.
Stephenson T; Pinto Pereira SM; Shafran R; de Stavola BL; Rojas N; McOwat K; Simmons R; Zavala M; O'Mahoney L; Chalder T; Crawley E; Ford TJ; Harnden A; Heyman I; Swann O; Whittaker E; ; Ladhani SN
Lancet Child Adolesc Health; 2022 Apr; 6(4):230-239. PubMed ID: 35143770
[TBL] [Abstract][Full Text] [Related]
7. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study).
Stephenson T; Shafran R; De Stavola B; Rojas N; Aiano F; Amin-Chowdhury Z; McOwat K; Simmons R; Zavala M; Consortium C; Ladhani SN;
BMJ Open; 2021 Aug; 11(8):e052838. PubMed ID: 34446502
[TBL] [Abstract][Full Text] [Related]
8. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
[TBL] [Abstract][Full Text] [Related]
9. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study.
Pinto Pereira SM; Nugawela MD; Stephenson T; Foret-Bruno P; Dalrymple E; Xu L; Whittaker E; Heyman I; Ford T; Segal T; Chalder T; Ladhani SN; Mensah AA; McOwat K; Simmons R; ; Shafran R
Sci Rep; 2024 Apr; 14(1):9957. PubMed ID: 38693285
[TBL] [Abstract][Full Text] [Related]
10. Predictive model for long COVID in children 3 months after a SARS-CoV-2 PCR test.
Nugawela MD; Stephenson T; Shafran R; De Stavola BL; Ladhani SN; Simmons R; McOwat K; Rojas N; Dalrymple E; Cheung EY; Ford T; Heyman I; Crawley E; Pinto Pereira SM
BMC Med; 2022 Nov; 20(1):465. PubMed ID: 36447237
[TBL] [Abstract][Full Text] [Related]
11. A Cross-Sectional Study of the Health of Emerging Young Adults in England Following a COVID-19 Infection.
Newlands F; Rojas NK; Nugawela M; Pinto Pereira SM; Buszewicz M; Chalder T; Cheung EY; Dalrymple E; Ford T; Heyman I; Ladhani SN; McOwat K; Simmons R; Stephenson T; Shafran R
J Adolesc Health; 2023 Jul; 73(1):20-28. PubMed ID: 37024311
[TBL] [Abstract][Full Text] [Related]
12. Developing survey weights to ensure representativeness in a national, matched cohort study: results from the children and young people with Long Covid (CLoCk) study.
Rojas NK; De Stavola BL; Norris T; Cortina-Borja M; Nugawela MD; Hargreaves D; Dalrymple E; McOwat K; Simmons R; Stephenson T; Shafran R; ; Pereira SMP
BMC Med Res Methodol; 2024 Jun; 24(1):134. PubMed ID: 38902672
[TBL] [Abstract][Full Text] [Related]
13. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies.
Behnood SA; Shafran R; Bennett SD; Zhang AXD; O'Mahoney LL; Stephenson TJ; Ladhani SN; De Stavola BL; Viner RM; Swann OV
J Infect; 2022 Feb; 84(2):158-170. PubMed ID: 34813820
[TBL] [Abstract][Full Text] [Related]
14. Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study.
Panagi L; White SR; Pinto Pereira SM; Nugawela MD; Heyman I; Sharma K; Stephenson T; Chalder T; Rojas NK; Dalrymple E; McOwat K; Simmons R; Swann O; ; Ford T; Shafran R
PLoS Med; 2024 Jan; 21(1):e1004315. PubMed ID: 38266043
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.
Bertran M; Amin-Chowdhury Z; Davies HG; Allen H; Clare T; Davison C; Sinnathamby M; Seghezzo G; Kall M; Williams H; Gent N; Ramsay ME; Ladhani SN; Oligbu G
PLoS Med; 2022 Nov; 19(11):e1004118. PubMed ID: 36346784
[TBL] [Abstract][Full Text] [Related]
16. Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales.
Swann OV; Lone NI; Harrison EM; Tomlinson LA; Walker AJ; Seaborne MJ; Pollock L; Farrell J; Hall PS; Seth S; Williams TC; Preston J; Ainsworth JS; Semple FF; Baillie JK; Katikireddi SV; Akbari A; Lyons R; Simpson CR; Semple MG; Goldacre B; Brophy S; Sheikh A; Docherty AB
BMJ Open; 2022 Nov; 12(11):e063271. PubMed ID: 36356998
[TBL] [Abstract][Full Text] [Related]
17. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
18. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
